Advertisements
Advertisements
प्रश्न
Who was the first patient who was given gene therapy? Why was the given treatment recurrent in nature?
Advertisements
उत्तर
The first clinical gene therapy was given in 1990 to a 4-year-old girl with adenosine deaminase (ADA) deficiency. This enzyme is crucial for the immune system to function. The disorder is caused due to the deletion of the gene for adenosine deaminase. In some children ADA deficiency can be cured by bone marrow transplantation; in others it can be treated by – enzyme replacement therapy, in which functional ADA is given to the patient by injection. But the problem- with both of these approaches that they are not completely curative. As a first step towards gene therapy, lymphocytes from the blood of the patient are grown in a culture outside the body. A functional ADA cDNA (using a retroviral vector) is then introduced into these lymphocytes, which are subsequently returned to the patient. However, as these cells are not immortal, the patient requires “periodic infusion of such genetically engineered lymphocytes. However, if the gene isolate from marrow cells producing ADA is introduced into cells at early embryonic stages, it could be a permanent cure.
APPEARS IN
संबंधित प्रश्न
Why do children cured by enzyme-replacement therapy adenosine deaminase deficiency need periodic treatment?
How did an American Company, Eli Lilly use the knowledge of r-DNA technology to produce human insulin?
State the role of C-peptide in human insulin.
The first clinical gene therapy was done for the treatment of ________.
The genetic defect adenosine deaminase deficiency may be cured permanently by ____________.
How is the amplification of a gene sample of interest carried out using PCR?
Explain how “Rosie” is different from a normal cow.
How was Insulin obtained before the advent of rDNA technology? What were the problems encountered?
Explain how recombinant Insulin can be produced.
A patient suffering from diabetes mellitus will have ______.
With regard to insulin choose the correct options.
- C-peptide is not present in mature insulin.
- The insulin produced by rDNA technology has C-peptide.
- The pro-insulin has C-peptide.
- A-peptide and B-peptide of insulin are interconnected by disulphide bridges.
Choose the correct answer from the options given below.
For effective treatment of the disease, early diagnosis and understanding of its pathophysiology is very important. Which of the following molecular diagnostic techniques is very useful for early detection?
The Adenosine deaminase deficiency results in ______.
Give the full form of ELISA. Which disease can be detected using it? Discuss the principle underlying the test.
What is a recombinant DNA vaccine? Give two examples.
A cell-free method of amplifying DNA first developed in the mid 1980's revolutionised the field of biotechnology, Name the method and explain the basic steps of the technique involved.
A host cell must be made competent, before it is able to receive an rDNA. Justify.
Explain how recombinant human insulin was prepared in 1983 by Eli Lily an American company.
The graph given below indicates the administration of the first (L) and second dose (M) of a vaccine. The corresponding response of the body is indicated by X, and Y. Interpret the graph and explain the reason for such a response shown by the body.
